Loading clinical trials...
Loading clinical trials...
Follicular Lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is incurable with conventional treatment and the disease...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Genmab
Collaborators
NCT06191744 · Follicular Lymphoma (FL)
NCT06043011 · Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), and more
NCT04488354 · Relapsed/Refractory B-cell Lymphomas, Diffuse Large B-Cell Lymphoma (DLBCL), and more
NCT05888493 · Follicular Lymphoma (FL)
NCT07550855 · Follicular Lymphoma (FL)
The University of Arizona Cancer Center - North Campus /ID# 228862
Tucson, Arizona
University of Arkansas for Medical Sciences /ID# 227198
Little Rock, Arkansas
Alta Bates Summit Medical Center for Research /ID# 229428
Berkeley, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions